Femara (letrozole) is a type II (non-steroidal) third generation aromatase inhibitor. Clinically it is used to treat postmenopausal women with either estrogen receptor positive or estrogen receptor unknown breast cancer.
T:00862781331412 C:008618027562183
Skype:mark (at)carphetin dot com
Email:mark (at)carphetin dot com